The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2009

Filed:

May. 19, 2004
Applicants:

Ian Robert Baldwin, Stevenage, GB;

Michael David Barker, Stevenage, GB;

Anthony William Dean, Stevenage, GB;

Colin David Eldred, Stevenage, GB;

Brian Evans, Stevenage, GB;

Sharon Lisa Gough, Stevenage, GB;

Stephen Barry Guntrip, Stevenage, GB;

Julie Nicole Hamblin, Stevenage, GB;

Stuart Holman, Stevenage, GB;

Paul Jones, Stevenage, GB;

Mika Kristian Lindvall, Stevenage, GB;

Christopher James Lunniss, Stevenage, GB;

Tracy Jane Redfern, Stevenage, GB;

Alison Judith Redgrave, Stevenage, GB;

John Edward Robinson, Stevenage, GB;

Michael Woodrow, Stevenage, GB;

Inventors:

Ian Robert Baldwin, Stevenage, GB;

Michael David Barker, Stevenage, GB;

Anthony William Dean, Stevenage, GB;

Colin David Eldred, Stevenage, GB;

Brian Evans, Stevenage, GB;

Sharon Lisa Gough, Stevenage, GB;

Stephen Barry Guntrip, Stevenage, GB;

Julie Nicole Hamblin, Stevenage, GB;

Stuart Holman, Stevenage, GB;

Paul Jones, Stevenage, GB;

Mika Kristian Lindvall, Stevenage, GB;

Christopher James Lunniss, Stevenage, GB;

Tracy Jane Redfern, Stevenage, GB;

Alison Judith Redgrave, Stevenage, GB;

John Edward Robinson, Stevenage, GB;

Michael Woodrow, Stevenage, GB;

Assignee:

Glaxo Group Limited, Greenford, Middlesex, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 215/38 (2006.01); C07D 215/44 (2006.01);
U.S. Cl.
CPC ...
Abstract

There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R, RRRand Rare as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.


Find Patent Forward Citations

Loading…